Cystic Fibrosis - Related Diabetes
<p class="16" style="text-align: justify; line-height: 114%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;" align="justif...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Kazimierz Wielki University,
2021-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <p class="16" style="text-align: justify; line-height: 114%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;" align="justify"><span style="font-family: 'Times New Roman'; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Cystic fibrosis (CF) is life-shortening autosomal recessive disease, caused by mutations in the cystic fibrosis transmembrane conductance regulator protein. The most common of CF complications is cystic fibrosis-related diabetes (CFRD). </span><span style="font-family: 'Times New Roman';">The pathophysiology of CFRD is complex. The best test for screening and diagnosis of CFRD is the oral glucose tolerance test (OGTT). Insulin therapy is a treatment of choice in CFDR pharmacotherapy. </span><span class="15" style="font-family: 'Times New Roman';">An inseparable element of CFRD therapy is also physical activity and diet.</span></p> |
|---|---|
| Item Description: | 2391-8306 10.12775/JEHS.2021.11.06.005 |